These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 33111350)

  • 1. "Camel humps"-shaped red blood cell histogram in a woman with extreme anemia treated with intravenous iron.
    Beverina I; Scalvini R; Brando B
    Transfusion; 2021 Feb; 61(2):348-349. PubMed ID: 33111350
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaemia tolerance: bridging with intravenous ferric carboxymaltose in a patient with acute post-haemorrhagic anaemia.
    Hönemann CW; Doll D; Kampmeier T; Ertmer C; Hagemann O; Hahnenkamp K
    Br J Anaesth; 2012 Jan; 108(1):167-8. PubMed ID: 22157459
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intravenous ferric carboxymaltose for the treatment of anemia in chronic renal disease].
    Merino JL; Bueno B; Campos MA; Amézquita Y
    Rev Clin Esp (Barc); 2014; 214(5):282-3. PubMed ID: 24582410
    [No Abstract]   [Full Text] [Related]  

  • 4. Iron supplementation in a case of severe iron deficiency anaemia.
    Füllenbach C; Triphaus C; Glaser P; Ziebart A; Zacharowski K; Meybohm P; Choorapoikayil S
    Br J Anaesth; 2018 Aug; 121(2):502-504. PubMed ID: 30032895
    [No Abstract]   [Full Text] [Related]  

  • 5. Preoperative Intravenous Iron and Erythropoietin to Treat Severe Anemia in Patient With Stage 4 Kidney Disease Before Oncologic Surgery: A Case Report.
    Luan-Erfe BM; Yilmaz M; Sweitzer B
    A A Pract; 2020 Jun; 14(8):e01234. PubMed ID: 32496428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with ferric carboxymaltose in the management of anemia in acute gastrointestinal bleeding.
    Ballester-Clau R; Torres Vicente G; Voltà-Pardo T; López-Barroso L; Cucala-Ramos M; Reñé-Espinet JM; Planella de Rubinat M
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):116-122. PubMed ID: 30335628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of intravenous iron treatment for chemotherapy-induced anemia: A prospective Phase II pilot clinical trial in South Korea.
    Jang JH; Kim Y; Park S; Kim K; Kim SJ; Kim WS; Jung CW; Lee J; Lee SH
    PLoS Med; 2020 Jun; 17(6):e1003091. PubMed ID: 32511251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypophosphatemia, a poorly known adverse reaction of intravenous use of iron].
    Barea Mendoza JA; Gredilla Zubiría I; González Olmedo J; Mateo Alvarez S
    Med Clin (Barc); 2014 Sep; 143(6):284-5. PubMed ID: 24461741
    [No Abstract]   [Full Text] [Related]  

  • 9. Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life.
    Befrits R; Wikman O; Blomquist L; Hjortswang H; Hammarlund P; Bajor A; Klintman D; Blom H
    Scand J Gastroenterol; 2013 Sep; 48(9):1027-32. PubMed ID: 23889159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Intravenous Iron in Anemic Patients Undergoing Major Abdominal Surgery May Not PREVENTT Blood Transfusions But Still Contribute to the Objectives of Patient Blood Management.
    Hardy JF; Farmer SL; Auerbach M; Frank SM; Javidroozi M; Leahy MF; Meier J; Ozawa S; Shander A
    Anesth Analg; 2021 Apr; 132(4):1174-1177. PubMed ID: 33723195
    [No Abstract]   [Full Text] [Related]  

  • 11. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery.
    Bisbe E; García-Erce JA; Díez-Lobo AI; Muñoz M;
    Br J Anaesth; 2011 Sep; 107(3):477-8. PubMed ID: 21841061
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness.
    ; Litton E; Baker S; Erber WN; Farmer S; Ferrier J; French C; Gummer J; Hawkins D; Higgins A; Hofmann A; De Keulenaer B; McMorrow J; Olynyk JK; Richards T; Towler S; Trengove R; Webb S;
    Intensive Care Med; 2016 Nov; 42(11):1715-1722. PubMed ID: 27686346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in intravenous iron treatment.
    Marx JJ
    Arzneimittelforschung; 2010; 60(6a):341-4. PubMed ID: 20648925
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy.
    Froessler B; Gajic T; Dekker G; Hodyl NA
    Arch Gynecol Obstet; 2018 Jul; 298(1):75-82. PubMed ID: 29740690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia.
    Calleja JL; Delgado S; del Val A; Hervás A; Larraona JL; Terán Á; Cucala M; Mearin F;
    Int J Colorectal Dis; 2016 Mar; 31(3):543-51. PubMed ID: 26694926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.
    Evstatiev R; Marteau P; Iqbal T; Khalif IL; Stein J; Bokemeyer B; Chopey IV; Gutzwiller FS; Riopel L; Gasche C;
    Gastroenterology; 2011 Sep; 141(3):846-853.e1-2. PubMed ID: 21699794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.
    Mahey R; Kriplani A; Mogili KD; Bhatla N; Kachhawa G; Saxena R
    Int J Gynaecol Obstet; 2016 Apr; 133(1):43-8. PubMed ID: 26868063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.
    Urato AC
    Obstet Gynecol; 2008 Sep; 112(3):703. PubMed ID: 18757678
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of Intravenous Ferric Carboxy-maltose in Pregnant Women with Iron Deficiency Anaemia.
    Mishra V; Gandhi K; Roy P; Hokabaj S; Shah KN
    J Nepal Health Res Counc; 2017 Sep; 15(2):96-99. PubMed ID: 29016575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoiesis-stimulating agents and blood transfusion: French healthcare payer perspective.
    Luporsi E; Mahi L; Morre C; Wernli J; de Pouvourville G; Bugat R
    J Med Econ; 2012; 15(2):225-32. PubMed ID: 22077267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.